Sebastien Foulquier
Overview
Explore the profile of Sebastien Foulquier including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
455
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vangrieken P, Scheijen J, Schiffers P, van de Waarenburg M, Foulquier S, Schalkwijk C
Sci Rep
. 2025 Feb;
15(1):6025.
PMID: 39972072
Methylglyoxal (MGO), a glycolysis by-product and precursor to advanced glycation endproducts (AGEs), is associated with glucose intolerance, type 2 diabetes, and vascular dysfunction. This study examined the long-term effects of...
2.
Manukjan N, Fulton D, Ahmed Z, Blankesteijn W, Foulquier S
Neural Regen Res
. 2024 Dec;
20(1):191-192.
PMID: 39657085
No abstract available.
3.
Berends E, Vangrieken P, Amiri N, van de Waarenburg M, Scheijen J, Hermes D, et al.
Mol Neurobiol
. 2024 Oct;
62(4):4190-4202.
PMID: 39414727
Diabetes and other age-related diseases are associated with an increased risk of cognitive impairment, but the underlying mechanisms remain poorly understood. Methylglyoxal (MGO), a by-product of glycolysis and a major...
4.
Berends E, Pencheva M, van de Waarenburg M, Scheijen J, Hermes D, Wouters K, et al.
J Physiol
. 2024 Sep;
602(22):6209-6223.
PMID: 39316027
Diabetes is associated with cognitive impairment, but the underlying mechanism remains unclear. Methylglyoxal (MGO), a precursor to advanced glycation endproducts (AGEs), is elevated in diabetes and linked to microvascular dysfunction....
5.
van der Laan K, Reesink K, Lambrichts S, Bitsch N, van der Taelen L, Foulquier S, et al.
J Biomech
. 2024 Jun;
171:112190.
PMID: 38897049
Biological tissues decay over time after harvesting, which alters their biomechanical properties. This poses logistical challenges for studies investigating passive arterial biomechanics as tissues need to be characterized shortly after...
6.
Manukjan N, Chau S, Caiment F, van Herwijnen M, Smeets H, Fulton D, et al.
Mol Neurobiol
. 2023 Dec;
61(7):4854-4867.
PMID: 38147228
The blood-brain barrier consists of tightly connected endothelial cells protecting the brain's microenvironment from the periphery. These endothelial cells are characterized by specific tight junction proteins such as Claudin-5 and...
7.
Nelissen E, Schepers M, Ponsaerts L, Foulquier S, Bronckaers A, Vanmierlo T, et al.
Pharmacol Res
. 2023 Oct;
197:106970.
PMID: 37884069
Vascular cognitive impairment (VCI) describes neurodegenerative disorders characterized by a vascular component. Pathologically, it involves decreased cerebral blood flow (CBF), white matter lesions, endothelial dysfunction, and blood-brain barrier (BBB) impairments....
8.
Berends E, van Oostenbrugge R, Foulquier S, Schalkwijk C
Fluids Barriers CNS
. 2023 Oct;
20(1):75.
PMID: 37875994
The brain is a highly metabolically active organ requiring a large amount of glucose. Methylglyoxal (MGO), a by-product of glucose metabolism, is known to be involved in microvascular dysfunction and...
9.
Manukjan N, Majcher D, Leenders P, Caiment F, van Herwijnen M, Smeets H, et al.
Acta Neuropathol Commun
. 2023 Aug;
11(1):128.
PMID: 37550790
Cerebral small vessel disease is characterised by decreased cerebral blood flow and blood-brain barrier impairments which play a key role in the development of white matter lesions. We hypothesised that...
10.
Colin M, Delaitre C, Foulquier S, Dupuis F
Molecules
. 2023 Jul;
28(14).
PMID: 37513355
The AT receptor has mainly been associated with the pathological effects of the renin-angiotensin system (RAS) (e.g., hypertension, heart and kidney diseases), and constitutes a major therapeutic target. In contrast,...